BillionToOne
BillionToOne is a precision diagnostics company that quantifies biology to create molecular diagnostics accurate, efficient, and accessible for all. The company's patent-pending molecular counter platform is a technology platform that can accurately count the DNA molecules to the single-count level. BillionToOne's mission is to make pre-natal testing safe and affordable for every expecting mother. Its novel technology can detect even single-gene disorders such as thalassemia through a simple blood test. They are replacing amniocentesis, an invasive and risky procedure that has a high miscarriage risk, with a safe and affordable blood test, starting in developing countries. BillionToOne was founded in 2016 and is headquartered in Menlo Park, California.
Domain
billiontoone.com
Country
United StatesIndustry
BiotechnologyEmployees
501-1000
Last Funding
$130.0M
Founded
2015
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does BillionToOne use?+
BillionToOne uses 17 technologies including Google Analytics, Google Font API, Google Tag Manager.
What industry is BillionToOne in?+
BillionToOne operates in the Biotechnology industry.
Where is BillionToOne based?+
BillionToOne is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026